Arkadiusz Czerwonka
Lublin, LU, Poland
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 32 publications
Author Correction: Cancer SLC43A2 alters T cell methionine metabolism and histone methylation.
Journal: Nature
Published: December 13, 2025
Selisistat, a SIRT1 inhibitor, enhances paclitaxel activity in luminal and triple-negative breast cancer: in silico, in vitro, and in vivo studies.
Journal: Journal of enzyme inhibition and medicinal chemistry
Published: February 12, 2025
The Notch inhibitor, FLI-06, increases the chemosensitivity of head and neck Squamous cell carcinoma cells to taxanes-based treatment.
Journal: Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie
Published: March 24, 2024
Optimization of a Three-Dimensional Culturing Method for Assessing the Impact of Cisplatin on Notch Signaling in Head and Neck Squamous Cell Carcinoma (HNSCC).
Journal: Cancers
Published: September 23, 2023
Modulation of Notch Signaling by Small-Molecular Compounds and Its Potential in Anticancer Studies.
Journal: Cancers
Published: August 01, 2023
Regulation of Notch1 Signalling by Long Non-Coding RNAs in Cancers and Other Health Disorders.
Journal: International journal of molecular sciences
Published: July 12, 2023
Isoquinoline Alkaloids from Coptis chinensis Franch: Focus on Coptisine as a Potential Therapeutic Candidate against Gastric Cancer Cells.
Journal: International journal of molecular sciences
Published: July 29, 2022
Antagonistic Pharmacological Interaction between Sirtuin Inhibitor Cambinol and Paclitaxel in Triple-Negative Breast Cancer Cell Lines: An Isobolographic Analysis.
Journal: International journal of molecular sciences
Published: May 24, 2022
Additive pharmacological interaction between sirtuin inhibitor cambinol and paclitaxel in MCF7 luminal and MDA-MB-231 triple-negative breast cancer cells.
Journal: Pharmacological reports : PR
Published: April 10, 2022
Assessment of Pharmacological Interactions between SIRT2 Inhibitor AGK2 and Paclitaxel in Different Molecular Subtypes of Breast Cancer Cells.
Journal: Cells
Published: February 13, 2022
Last Updated: 09/26/2026